MV TELEGRAPH DAILY NEWS
Glenview Capital, a major CVS Health shareholder, is expected to meet with company leadership on Monday to lay out proposed fixes for the struggling business, according to people familiar with the matter, a potential precursor to an activist push. The hedge fund has established a sizable position in the company, said some of the people. …
Continue reading “Main CVS shareholder plans activist push, meet with execs: sources”
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Novo Nordisk‘s blockbuster diabetes drug Ozempic may decrease the risk of opioid overdoses in certain patients, demonstrating its potential as an alternative treatment for opioid use disorder, according to a new study …
Continue reading “Novo Nordisk’s Ozempic could decrease threat of opioid overdoses: research”
Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office Building on May 15, 2024 in Washington, DC. Kevin Dietsch | Getty Images News | Getty Images The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the …
Continue reading “FTC sues drug middlemen for allegedly inflating insulin costs”
Tim Cook, chief executive officer of Apple Inc., during an event at Apple Park campus in Cupertino, California, US, on Monday, Sept. 9, 2024. Apple Inc. unveiled a new version of its smartwatch with a bigger screen and the ability to detect sleep apnea, part of an event Monday that will also include the iPhone …
Continue reading “FDA clears Apple’s sleep apnea detection characteristic to be used”
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business. …
Continue reading “$1 billion in value cuts, 10 product launches deliberate”
A sign with the company logo outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Earlier this …
Continue reading “Eli Lilly might develop into the primary $1 trillion healthcare inventory”
Shortly after the opening bell, we’ll be selling 10 shares of Eli Lilly at roughly $958 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 100 shares of LLY, decreasing its weighting to 2.85% from about 3.13%. Now that we are no longer restricted, we are selling some Eli Lilly shares. We downgraded Lilly …
Continue reading “We’re taking an almost 300% revenue on a scorching drug inventory”
Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage for the popular injection, such as those with Medicare. The move also aims to expand the supply of Zepbound in the U.S. as demand skyrockets, …
Continue reading “Eli Lilly releases new, cheaper type of weight reduction drug”
Images By Tang Ming Tung | DigitalVision | Getty Images The Biden administration on Friday said it will resume offering free at-home Covid-19 tests to American households in late September as the virus has gained a stronger foothold in the U.S. this summer. Americans will soon be able to use COVIDtests.gov to request four free …
Continue reading “U.S. will provide free at-home kits beginning late September”
Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo, according to initial results from a long-term study released Tuesday. The late-stage trial on tirzepatide, the active ingredient in the company’s weight loss injection Zepbound and diabetes …
Continue reading “Eli Lilly weight reduction drug cuts threat of creating diabetes in trial”
